Plunkett Research Online: Oasmia Pharmaceutical

OASMIA PHARMACEUTICAL (OASMY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vivesto AB is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers......



Oasmia Pharmaceutical
Ticker: OASMY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 18505440
Fax: 46 18510873
Address: Gustav III:s Boulevard 46
5th Floor
Solna, SE-169 73 Sweden

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description
Erik KinnmanCEO
Robert MaioranaCFO
See More
Vivesto AB is a specialty pharmaceutical company focused on the development of new therapeutic options for patients suffering from hard-to-treat cancers......See More See More

Auditor: KPMG AB
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (SEK)Bonus (SEK)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: